Trademark Overview
On Friday, February 6, 2026, a trademark application was filed for ELADYNOS with the United States Patent and Trademark Office. The USPTO has given the ELADYNOS trademark a serial number of 99637948. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, February 6, 2026. This trademark is owned by Radius Health, Inc.. The ELADYNOS trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for use in the treatment of bone diseases, connective tissue diseases, inflammatory diseases, blood diseases and hormonal disorders; Pharmaceutical preparations for use in the treatment of wasting and other muscle, fat and tissue loss caused by medical disorders or aging; Pharmaceutical preparations for use in hormone therapy; Pharmaceutical preparations for use in the treatment of cardiovascular diseases, central and peripheral nervous system diseases, cancer, gynecological diseases, rheumatic diseases, urological diseases, gastroenterological diseases, infectious diseases, dermatological diseases, autoimmune diseases, blood diseases, genital diseases, endocrine diseases, intestinal diseases, internal medicine diseases; Pharmaceutical preparations for use in the treatment of alopecia; Pharmaceutical preparations for use in the treatment of cognitive disorders and mood disorders; Pharmaceutical preparations for use in the treatment of diabetes and insulin-re...
